Home The Word Brain Fast Track My Amedeo FAQ About Flying Publisher   

Fast Track

Ear2MemoryFree App | Free PDF | Web
Learning languages on your smartphone
By BSK

Free Abstracts

  Prostate Cancer

  Free Subscription


Articles published in Proc Natl Acad Sci U S A

Retrieve available abstracts of 19 articles:
HTML format
Text format



Single Articles


    June 2017
  1. FEI T, Chen Y, Xiao T, Li W, et al
    Genome-wide CRISPR screen identifies HNRNPL as a prostate cancer dependency regulating RNA splicing.
    Proc Natl Acad Sci U S A. 2017 Jun 13. pii: 201617467.
    PubMed     Text format     Abstract available


    May 2017

  2. Correction for Dash et al., Apogossypol derivative BI-97C1 (Sabutoclax) targeting Mcl-1 sensitizes prostate cancer cells to mda-7/IL-24-mediated toxicity.
    Proc Natl Acad Sci U S A. 2017 May 22. pii: 201706353.
    PubMed     Text format    


    March 2017
  3. BANERJEE S, Zare RN, Tibshirani RJ, Kunder CA, et al
    Diagnosis of prostate cancer by desorption electrospray ionization mass spectrometric imaging of small metabolites and lipids.
    Proc Natl Acad Sci U S A. 2017 Mar 14. pii: 201700677.
    PubMed     Text format     Abstract available


    November 2016
  4. LORENZO G, Scott MA, Tew K, Hughes TJ, et al
    Tissue-scale, personalized modeling and simulation of prostate cancer growth.
    Proc Natl Acad Sci U S A. 2016 Nov 16. pii: 201615791.
    PubMed     Text format     Abstract available


    October 2016
  5. FERRARA F, Staquicini DI, Driessen WH, D'Angelo S, et al
    Targeted molecular-genetic imaging and ligand-directed therapy in aggressive variant prostate cancer.
    Proc Natl Acad Sci U S A. 2016 Oct 24. pii: 201615400.
    PubMed     Text format     Abstract available


    September 2016
  6. STOYANOVA T, Riedinger M, Lin S, Faltermeier CM, et al
    Activation of Notch1 synergizes with multiple pathways in promoting castration-resistant prostate cancer.
    Proc Natl Acad Sci U S A. 2016 Sep 30. pii: 201614529.
    PubMed     Text format     Abstract available


  7. ALHASAN AH, Scott AW, Wu JJ, Feng G, et al
    Circulating microRNA signature for the diagnosis of very high-risk prostate cancer.
    Proc Natl Acad Sci U S A. 2016 Sep 6. pii: 201611596.
    PubMed     Text format     Abstract available


    June 2016
  8. AHMAD I, Mui E, Galbraith L, Patel R, et al
    Sleeping Beauty screen reveals Pparg activation in metastatic prostate cancer.
    Proc Natl Acad Sci U S A. 2016 Jun 29. pii: 201601571.
    PubMed     Text format     Abstract available


  9. RAINA K, Lu J, Qian Y, Altieri M, et al
    PROTAC-induced BET protein degradation as a therapy for castration-resistant prostate cancer.
    Proc Natl Acad Sci U S A. 2016 Jun 6. pii: 201521738.
    PubMed     Text format     Abstract available


    May 2016
  10. KOMURA K, Jeong SH, Hinohara K, Qu F, et al
    Resistance to docetaxel in prostate cancer is associated with androgen receptor activation and loss of KDM5D expression.
    Proc Natl Acad Sci U S A. 2016 May 16. pii: 201600420.
    PubMed     Text format     Abstract available


    April 2016
  11. PARK JW, Lee JK, Phillips JW, Huang P, et al
    Prostate epithelial cell of origin determines cancer differentiation state in an organoid transformation assay.
    Proc Natl Acad Sci U S A. 2016;113:4482-7.
    PubMed     Text format     Abstract available


    March 2016
  12. SYKES EA, Dai Q, Sarsons CD, Chen J, et al
    Tailoring nanoparticle designs to target cancer based on tumor pathophysiology.
    Proc Natl Acad Sci U S A. 2016;113:E1142-51.
    PubMed     Text format     Abstract available


    February 2016
  13. HOSOYA H, Dobroff AS, Driessen WH, Cristini V, et al
    Integrated nanotechnology platform for tumor-targeted multimodal imaging and therapeutic cargo release.
    Proc Natl Acad Sci U S A. 2016;113:1877-82.
    PubMed     Text format     Abstract available


    January 2016
  14. FENG FY, Kothari V
    Driven to metastasize: Kinases as potential therapeutic targets in prostate cancer.
    Proc Natl Acad Sci U S A. 2016 Jan 8. pii: 201522938.
    PubMed     Text format    


  15. LINCH SN, Kasiewicz MJ, McNamara MJ, Hilgart-Martiszus IF, et al
    Combination OX40 agonism/CTLA-4 blockade with HER2 vaccination reverses T-cell anergy and promotes survival in tumor-bearing mice.
    Proc Natl Acad Sci U S A. 2016 Jan 4. pii: 201510518.
    PubMed     Text format     Abstract available


    November 2015
  16. FALTERMEIER CM, Drake JM, Clark PM, Smith BA, et al
    Functional screen identifies kinases driving prostate cancer visceral and bone metastasis.
    Proc Natl Acad Sci U S A. 2015 Nov 30. pii: 201521674.
    PubMed     Text format     Abstract available


  17. ELLIS L, Loda M
    Advanced neuroendocrine prostate tumors regress to stemness.
    Proc Natl Acad Sci U S A. 2015;112:14406-7.
    PubMed     Text format    


  18. FEHR D, Veeraraghavan H, Wibmer A, Gondo T, et al
    Automatic classification of prostate cancer Gleason scores from multiparametric magnetic resonance images.
    Proc Natl Acad Sci U S A. 2015;112:E6265-E6273.
    PubMed     Text format     Abstract available


  19. COSTA HA, Leitner MG, Sos ML, Mavrantoni A, et al
    Discovery and functional characterization of a neomorphic PTEN mutation.
    Proc Natl Acad Sci U S A. 2015;112:13976-81.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Prostate Cancer is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: